El uso de la Resonancia Magnética Multiparamétrica en el diagnóstico de cáncer de próstata

Authors

  • Karla Gutierrez C. Clínica Internacional
  • Pedro Huaripata A. Clínica Internacional

DOI:

https://doi.org/10.56838/icmed.v12i2.90

Keywords:

Prostate cancer, multiparametric magnetic resonance imaging, Prostate Specific Antigen

Abstract

We present the clinical, laboratory and multiparametric MRI characteristics of patients diagnosed with prostate cancer in patients in a private health institution in Lima. An observational, retrospective study was conducted in outpatients who were admitted for study by prostate-specific antigen tests, MRI and transrectal ultrasound-guided biopsy results during the months of March to May 2022, with a positive diagnosis for prostate cancer. The analysis was performed with SPSS software version 25.0. It was observed that the median age was 64 years, having a PIRADS value greater than 4 as a greater probability of risk of prostate cancer, likewise the increase of each PSA point there is a greater risk of 11.6% of probability of presenting the pathology and this increases with the use of multiparametric magnetic resonance imaging.

Downloads

Download data is not yet available.

Downloads

Published

2022-07-31

Issue

Section

Artículo original

How to Cite

1.
El uso de la Resonancia Magnética Multiparamétrica en el diagnóstico de cáncer de próstata. Interciencia méd. [Internet]. 2022 Jul. 31 [cited 2024 Nov. 23];12(2):5-12. Available from: https://intercienciamedica.com/index.php/intercienciamedica/article/view/90